The Relationship Between Fracture and Mortality in a Chinese Maintenance Hemodialysis Patients Cohort

References

• Zhang L, Long J, Jiang W, et al. Trends in Chronic Kidney Disease in China. N Engl J Med. 2016;375(9):905–906. PMID: 27579659. doi:10.1056/NEJMc1602469
   PubMed Web of Science ®Google Scholar
• Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in china: results from the sixth china chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310. PMID: 36804760; PMCID: PMC9941971. doi:10.1001/jamainternmed.2022.6817
   PubMed Web of Science ®Google Scholar
• Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I. Hip fracture trends in japanese dialysis patients, 2008–2013. Am J Kidney Dis. 2018;71(2):173–181. PMID: 29162337. doi:10.1053/j.ajkd.2017.07.017
   PubMed Web of Science ®Google Scholar
• Iseri K, Carrero JJ, Evans M, et al. Secular trends in Hip fracture incidence and subsequent mortality in dialysis patients and the general population in Sweden. Bone. 2021;147:115909. PMID: 33716163. doi:10.1016/j.bone.2021.115909
   PubMed Web of Science ®Google Scholar
• Tentori F, McCullough K, Kilpatrick RD, et al. High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2014;85(1):166–173. PMID: 23903367; PMCID: PMC3910091. doi:10.1038/ki.2013.279
   PubMed Web of Science ®Google Scholar
• Alem AM, Sherrard DJ, Gillen DL, et al. Increased risk of Hip fracture among patients with end-stage renal disease. Kidney Int. 2000;58(1):396–399. PMID: 10886587. doi:10.1046/j.1523-1755.2000.00178.x
   PubMed Web of Science ®Google Scholar
• Rasmussen NH, Sarodnik C, Bours SPG, et al. The pattern of incident fractures according to fracture site in people with T1D. Osteoporos Int. 2022;33(3):599–610. PMID: 34617151. doi:10.1007/s00198-021-06175-z
   PubMed Web of Science ®Google Scholar
• Sofue T, Nakagawa N, Kanda E, et al. Prevalence of anemia in patients with chronic kidney disease in Japan: a nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020;15(7):e0236132. PMID: 32687544; PMCID: PMC7371174. doi:10.1371/journal.pone.0236132
   PubMed Web of Science ®Google Scholar
• Maezawa K, Nozawa M, Maruyama Y, Sakuragi E, Sugimoto M, Ishijima M. Comparison of anemia, renal function, and nutritional status in older women with femoral neck fracture and older women with osteoarthritis of the Hip joint. J Orthop Sci. 2023;28(2):380–384. PMID: 35000815. doi:10.1016/j.jos.2021.12.009
   PubMed Web of Science ®Google Scholar
• Suresh S, Wright EC, Wright DG, Abbott KC, Noguchi CT. Erythropoietin treatment and the risk of Hip fractures in hemodialysis patients. J Bone Miner Res. 2021;36(7):1211–1219. PMID: 33949002; PMCID: PMC8360057. doi:10.1002/jbmr.4297
   PubMed Web of Science ®Google Scholar
• McCullough PA. Phosphate control: the next frontier in dialysis cardiovascular mortality. Cardiorenal Med. 2021;11(3):123–132. PMID: 34120113. doi:10.1159/000516286
   PubMed Web of Science ®Google Scholar
• Fusaro M, Holden R, Lok C, et al. Phosphate and bone fracture risk in chronic kidney disease patients. Nephrol Dial Transplant. 2021;36(3):405–412. PMID: 31620773. doi:10.1093/ndt/gfz196
   PubMed Web of Science ®Google Scholar
• González-Parra E, Bover J, Herrero J, et al. Control of phosphorus and prevention of fractures in the kidney patient. Nefrologia. 2021;41(1):7–14. PMID: 36165365. doi:10.1016/j.nefroe.2021.02.003
   Web of Science ®Google Scholar
• Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing hemodialysis: the LANDMARK randomized clinical trial. JAMA. 2021;325(19):1946–1954. PMID: 34003226; PMCID: PMC8132143. doi:10.1001/jama.2021.4807
   PubMed Web of Science ®Google Scholar
• Barrera-Baena P, Rodríguez-García M, Rodríguez-Rubio E, et al.; of COSMOS. Serum phosphate is associated with increased risk of bone fragility fractures in hemodialysis patients. Nephrol Dial Transplant. 2023;39(4):618–626. PMID: 37660283; PMCID: PMC10966329. doi:10.1093/ndt/gfad190
   PubMed Web of Science ®Google Scholar
• Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey P. Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018;93(6):1475–1482. PMID: 29525393. doi:10.1016/j.kint.2017.12.014
   PubMed Web of Science ®Google Scholar
• Pyrża M, Głogowski T, Wieliczko M, et al. Malignancy prevalence in the dialyzed population and in waitlisted potential kidney transplant recipients. Transplant Proc. 2022;54(4):930–933. PMID: 35279304. doi:10.1016/j.transproceed.2022.01.025
   PubMed Web of Science ®Google Scholar
• Kwon SK, Han JH, Kim HY, et al. The incidences and characteristics of various cancers in patients on dialysis: a korean nationwide study. J Korean Med Sci. 2019;34(25):e176. PMID: 31243935; PMCID: PMC6597487. doi:10.3346/jkms.2019.34.e176
   PubMed Web of Science ®Google Scholar
• Kwon YE, Choi HY, Oh HJ, Ahn SY, Ryu DR, Kwon YJ. Vertebral fracture is associated with myocardial infarction in incident hemodialysis patients: a Korean nationwide population-based study. Osteoporos Int. 2020;31(10):1965–1973. PMID: 32394062. doi:10.1007/s00198-020-05423-y
   PubMed Web of Science ®Google Scholar
• Zhao X, Gan L, Niu Q, et al. Clinical outcomes in patients on hemodialysis with congestive heart failure. Kidney Dis. 2023;9(4):306–316. PMID: 37900002; PMCID: PMC10601911. doi:10.1159/000529802
   Google Scholar